Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Breast Cancer Res Treat. 2017 Dec 22;168(3):755–761. doi: 10.1007/s10549-017-4603-z

Table 4.

Treatment-specific symptoms and general functioning predicting change in physical activity during weight loss maintenance (6–18 months)

DV: bouted MVPA min/weeka
Variable Beta Std. Error P value Confidence Interval (95%)
6 month BCPT
Musculoskeletal
.015 .032 .648 −.048, .078
6 month BCPT Vasomotor .011 .031 .727 −.050, .071
6 month BCPT Cognitive −.048 .029 .102 −.106, .010
6 month SF-12 Physical .043 .010 .001 .024, .063
6 month SF-12 Mental .021 .010 .028 .002, .040

Note: Model included the following covariates: age, anti-hormone therapy at 6-months, chemotherapy treatment history, time since treatment completion, randomization assignment, education, rurality, and baseline BMI.

Unstandardized regression coefficients are presented.

a

Dependent variable was square-root transformed

BCPT = Breast Cancer Prevention Trial Symptom Checklist

MVPA = moderate to vigorous physical activity